Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis

Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis

Abstract Background Tocilizumab (TCZ), an interleukin-6 receptor antagonist, is approved for treating rheumatic diseases and has demonstrated efficacy in managing refractory non-infectious uveitis (NIU). This retrospective study aimed to investigate the long-term effects of TCZ on inflammation in th...

Full description

Saved in:
Bibliographic Details
Main Authors: Lynn S. zur Bonsen, Daniel Schulze, Steffen E. Künzel, Anne Rübsam, Uwe Pleyer, Dominika Pohlmann
Format: Article
Language:English
Published: SpringerOpen 2024-11-01
Series:Journal of Ophthalmic Inflammation and Infection
Subjects:
Angiography
Birdshot uveitis
Choroidal inflammation
Indocyanine green
Interleukin-6
Tocilizumab
Online Access:https://doi.org/10.1186/s12348-024-00443-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12348-024-00443-9

Similar Items